Novo Nordisk | NVO - Market Capitalization


Novo Nordisk reported DKK130.56B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
ANI Pharmaceuticals USD 2.04B 630M Sep/2025
Aurora Cannabis CAD 470.14M 146.16M Sep/2025
Bausch Health Companies USD 2.99B 417.38M Feb/2026
Bristol-Myers Squibb USD 123.58B 13.77B Feb/2026
Canopy Growth CAD 136.67M 644.68M Feb/2026
Corcept Therapeutics USD 3.82B 161M Feb/2026
Drreddys Laboratories INR 2.28B 9.41B Feb/2026
Eli Lilly USD 1.01T 3.37B Feb/2026
GlaxoSmithKline GBP 87.33B 12.98B Feb/2026
Merck USD 300.37B 39.11B Feb/2026
Nektar Therapeutics USD 113M 4M Sep/2023
Novartis USD 265.66B 9.48B Sep/2025
Novo Nordisk DKK 246.32B 60.06B Sep/2025
Novo Nordisk A/S DKK 1.54T 86.62B Feb/2026
Pacira USD 1.16B 51M Sep/2025
Perrigo USD 2.95B 698M Sep/2025
Phibro Animal Health USD 469M 48M Dec/2023
Prestige Brands USD 3.26B 289M Feb/2026
Sanofi EUR 100.88B 4.46B Dec/2025
Supernus Pharmaceuticals USD 2.92B 67M Feb/2026
Zoetis USD 57.53B 2.08B Feb/2026